Genmab A/S Stock

Genmab A/S Cash Flow per Share

The Operating Cash Flow per Share of Genmab A/S (GMAB.CO) as of Aug 14, 2026 is 18.92 USD. In the previous year, Operating Cash Flow per Share was 17.44 USD — a change of 8.49% (higher).

Cash Flow per Share

18.92USD

YoY

8.49%

Last updated:

Operating Cash Flow per Share of Genmab A/S is 2026 18.92 USD. Operating Cash Flow per Share of Genmab A/S was 2025 17.44 USD. It decreases by 8.49% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Operating Cash Flow per Share of Genmab A/S is 18.92 USD in 2026.

Operating Cash Flow per Share of Genmab A/S changed from 17.44 USD to 18.92 USD, representing a 8.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genmab A/S

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genmab A/S